CYP2J2 and ischemia: Moreover, cardiomyocyte-specific CYP2J2 overexpression attenuates cardiac ischemia-reperfusion injury by activating mitochondrial ATP-sensitive K+ channels and the p42/p44 MAPK pathway [47].